Youssef Toubouti

2.0k total citations · 2 hit papers
38 papers, 1.4k citations indexed

About

Youssef Toubouti is a scholar working on Surgery, Pharmacology and Epidemiology. According to data from OpenAlex, Youssef Toubouti has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pharmacology and 9 papers in Epidemiology. Recurrent topics in Youssef Toubouti's work include Inflammatory mediators and NSAID effects (9 papers), Ophthalmology and Visual Impairment Studies (8 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (7 papers). Youssef Toubouti is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Ophthalmology and Visual Impairment Studies (8 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (7 papers). Youssef Toubouti collaborates with scholars based in United States, Canada and United Kingdom. Youssef Toubouti's co-authors include Elham Rahme, Alan Barkun, Marc Bardou, Noel A. Brennan, Xu Cheng, Mark A. Bullimore, Myriam Martel, Dalila Benhaberou-Brun, Jamie Gregor and David Armstrong and has published in prestigious journals such as Nature Medicine, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Youssef Toubouti

36 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy in myopia control

2020 201 citations Noel A. Brennan, Youssef Toubouti et al. Progress in Retinal and Eye Research profile →
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

2023 111 citations Ingo K. Mellinghoff, Min Lu et al. Nature Medicine profile →

Peers

Countries citing papers authored by Youssef Toubouti

Since Specialization

Citations

This map shows the geographic impact of Youssef Toubouti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youssef Toubouti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youssef Toubouti more than expected).

Fields of papers citing papers by Youssef Toubouti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youssef Toubouti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youssef Toubouti. The network helps show where Youssef Toubouti may publish in the future.

Co-authorship network of co-authors of Youssef Toubouti

This figure shows the co-authorship network connecting the top 25 collaborators of Youssef Toubouti. A scholar is included among the top collaborators of Youssef Toubouti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youssef Toubouti. Youssef Toubouti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Indirect comparisons of relative efficacy estimates of zuranolone and selective serotonin reuptake inhibitors for postpartum depression 2024 ·Journal of Medical Economics ·Samantha Meltzer‐Brody, Margaret E. Gerbasi, (unknown), Youssef Toubouti, Sarah Smith, Neil Roskell, R. Tan, Shih‐Yin Chen, Kristina M. Deligiannidis	10
2	Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial breakdown → 2023 ·Nature Medicine ·Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen, Jennie Taylor, Elizabeth A. Maher, Isabel Arrillaga‐Romany, Katherine B. Peters, Benjamin M. Ellingson, Marc K. Rosenblum, Saewon Chun, Kha Le, Anna M. Tassinari, Sung Choe, Youssef Toubouti, Steven Schoenfeld, Shuchi S. Pandya, Islam Hassan, Lori Steelman, Jennifer Clarke, Timothy F. Cloughesy	111
3	Saturdays Orthodontic Appointments, Demand, and Patients\' Commitment 2023 ·The Journal of Contemporary Dental Practice ·Sawsan Tabbaa, Shankargouda Patil, Tarek El‐Bialy, Justin McDaniel, Youssef Toubouti, (unknown), (unknown)	0
4	Direct-to-consumer orthodontics 2022 ·The Journal of the American Dental Association ·Sawsan Tabbaa, (unknown), Youssef Toubouti, Humam Saltaji	3
5	Direct to consumer orthodontics: Exploring patient demographic trends and preferences 2020 ·American Journal of Orthodontics and Dentofacial Orthopedics ·(unknown), Sawsan Tabbaa, (unknown), Youssef Toubouti, Humam Saltaji	12
6	The effects of light scatter when using a photochromic vs. non-photochromic contact lens 2020 ·Journal of Optometry ·Billy R. Hammond, (unknown), (unknown), (unknown), Youssef Toubouti, Lisa Renzi‐Hammond	17
7	Efficacy in myopia control breakdown → 2020 ·Progress in Retinal and Eye Research ·Noel A. Brennan, Youssef Toubouti, Xu Cheng, Mark A. Bullimore	201
8	A contra-lateral comparison of the visual effects of a photochromic vs. non-photochromic contact lens 2019 ·Contact Lens and Anterior Eye ·Lisa Renzi‐Hammond, (unknown), (unknown), (unknown), Youssef Toubouti, Billy R. Hammond	19
9	Randomized Crossover Trial Evaluating the Impact of Senofilcon A Photochromic Lens on Driving Performance 2019 ·Optometry and Vision Science ·(unknown), Youssef Toubouti, (unknown)	10
10	Lid Wiper Epitheliopathy in Soft Contact Lens Wearers 2016 ·Optometry and Vision Science ·Marc Schulze, Sruthi Srinivasan, Sheila Hickson-Curran, David A. Berntsen, (unknown), Youssef Toubouti, Philip B. Morgan, Jason J. Nichols, Lyndon Jones, (unknown)	24
11	Resultant vertical prism in toric soft contact lenses 2015 ·Contact Lens and Anterior Eye ·Anna Sulley, (unknown), (unknown), Youssef Toubouti, (unknown)	14
12	Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses 2009 ·Gastrointestinal Endoscopy ·Alan Barkun, Myriam Martel, Youssef Toubouti, Elham Rahme, Marc Bardou	122
13	Do proton‐pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? 2007 ·Arthritis Care & Research ·Elham Rahme, Alan Barkun, Youssef Toubouti, Alissa Scalera, (unknown), Jacques LeLorier	34
14	Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada. 2006 ·PubMed ·Elham Rahme, Youssef Toubouti, Jacques LeLorier	6
15	Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: What is the potential impact of the withdrawal of rofecoxib? 2006 ·Arthritis Care & Research ·Elham Rahme, Elke Hunsche, Youssef Toubouti, Isabelle Chabot	4
16	Association between nonnaproxen NSAIDs, COX‐2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study 2006 ·Pharmacoepidemiology and Drug Safety ·Elham Rahme, Douglas J. Watson, Sheldon X. Kong, Youssef Toubouti, Jacques LeLorier	17
17	Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada 2006 ·Lara D. Veeken ·Elham Rahme, Youssef Toubouti, Elke Hunsche	9
18	Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population 2005 ·The American Journal of Medicine ·Elham Rahme, D. Choquette, Michèle Beaulieu, Louis Bessette, Lawrence Joseph, Youssef Toubouti, Jacques LeLorier	36
19	The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting 2004 ·The American Journal of Gastroenterology ·Alan Barkun, (unknown), Robert Enns, David Armstrong, Jamie Gregor, Richard N. Fedorak, Elham Rahme, Youssef Toubouti, Myriam Martel, Naoki Chiba, Carlo A Fallone, (unknown)	270
20	The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence 2003 ·Gastroenterology ·Elham Rahme, Alan Barkun, Youssef Toubouti, Marc Bardou	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact